The import of Theophylline and Aminophylline into Brazil is forecasted to decrease gradually from 41.78 thousand kilograms in 2024 to 38.65 thousand kilograms in 2028. From 2024 to 2025, there's a projected decline of approximately 1.94%, and this decreasing trend continues with about 1.93% from 2025 to 2026, 1.92% from 2026 to 2027, and 1.93% from 2027 to 2028.

Key trends to watch for in the coming years include:

Shifts in pharmaceutical needs and production capabilities within Brazil, which may impact import reliance.
Global supply chain dynamics, particularly concerning raw material availability and transportation costs.
Regulatory changes affecting pharmaceutical imports and domestic market conditions.